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Abstract
Background: Epidemiological studies of malaria in adults who live in malaria endemic areas are
scarce. More attention to the natural history of malaria affecting adults is needed to understand the
dynamics of malaria infection and its interaction with the immune system. The present study was
undertaken to investigate the clinical, parasitological and haematological status of adults exposed
to malaria, and to characterize parasites in these individuals who progressively acquire protective
immunity.
Methods: A cross-sectional survey of 249 adults was conducted in a malaria endemic area of
Mozambique. Clinical, parasitological and haematological status of the study population was
recorded. Sub-microscopic infections and multiplicity of infections were investigated using
polymerase chain reaction (PCR) and restriction fragment length polymorphism of Plasmodium
falciparum merozoite surface protein 2 (msp2).
Results: Prevalence of P. falciparum infection by microscopy (14%) and PCR (42%) decreased
progressively during adulthood, in parallel with an increase in the prevalence of sub-microscopic
infections. Anaemia was only related to parasitaemia as detected by PCR. Multiplicity of infection
decreased with age and was higher in subjects with high P. falciparum densities, highlighting density-
dependent constraints upon the PCR technique.
Conclusion: Adults of Manhiça progressively develop non-sterile, protective immunity against P.
falciparum malaria. The method of parasite detection has a significant effect on the observed natural
history of malaria infections. A more sensitive definition of malaria in adults should be formulated,
considering symptoms such as diarrhoea, shivering and headache, combined with the presence of
parasitaemia.
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Background
The epidemiology of malaria in adults who live in malaria
endemic areas is a neglected area of research. Malaria con-
trol strategies have focussed on children under the age of
5 years and pregnant women, as the majority of malaria-
related sickness and death is seen in these two groups [1].
However, early studies in West Africa showed that clinical
attacks of malaria also occur in adults living in areas of
high endemicity [2] and a recent report points out the
considerable contribution of malaria as a cause of death
in adults [3].
The risk of malaria attacks in residents of malaria endemic
areas falls as they become older [4], suggesting that pro-
tection is a function of age. This protective immunity is
sequentially being reflected first by a reduction of life-
threatening disease, then by a fall in the incidence of mild
malaria and finally by a reduction in parasite prevalence
[5]. The means by which acquired immunity develops is
still a matter of contention. It is likely that cumulative
exposure to the enormous repertoire of antigenic variants
of blood stage malaria parasites [6] plays an important
part. However, there is evidence which suggests that pro-
tection can be established after a relatively brief period of
exposure and lasts for many years [7,8]. Indeed, passive
transfer of naturally acquired immunity [9] and malariot-
herapy of syphilitic patients [10] have suggested that there
is a strong component of non-variant specific immunity
involved in the protection against malaria which may be
age-dependent.
The immune mechanisms that deal with a malarial infec-
tion probably change with age, as suggested by the age-
dependency of malariometric indices [11], the pyrogenic
threshold of parasitaemia [12], the speed with which
infections are controlled, the incidence of clinical epi-
sodes [7] and the parasitological complexity of individual
infections [13]. It is generally accepted that protective
immunity effectively prevents the severe clinical manifes-
tations of Plasmodium falciparum infections and substan-
tially reduces parasite loads, but does not prevent
infection [14]. The consequence of this process is that the
presence of blood-stage parasites in a semi-immune host
is not synonymous with disease. This, together with the
non-specificity of the malaria signs and symptoms in
adults, make the individual diagnosis of clinical malaria
in adults difficult in highly endemic areas.
Studies of malaria in semi-immune adults of Africa are
scarce [12,15-19]. More attention to the natural history of
malaria affecting adults is needed to understand the
dynamics of malaria infection and its interaction with the
immune system. The present study was undertaken to
investigate the clinical, parasitological and haematologi-
cal status of adults living in a region in Mozambique
where malaria is endemic, and to characterize parasites in
these individuals who progressively acquire protective
immunity.
Methods
Study area
The study took place at the Manhiça Health Research
Center, in Manhiça (Maputo Province), a rural area in
Southern Mozambique. The area, described in detail else-
where [20], is covered by a continuous demographic sur-
veillance system (DSS) run by CISM since 1996. Malaria
transmission is continuous, with intense seasonality. The
entomological inoculation rate at the time of the study
was 15 infective bites/person/year [21]. Anopheles funestus
is the main vector and most infections are caused by P. fal-
ciparum.
Cross sectional survey
A sample of 500 adults aged ≥ 15 years was selected ran-
domly from the 1999 demographic census. Potential par-
ticipants were invited to attend selected sites on a given
date during the period 26th July to the 4th August 1999.
Pregnant women and individuals who had taken anti-
malarial treatment in the week preceding sampling were
excluded. After written and witnessed informed consent
had been obtained, capillary blood samples were col-
lected by finger prick for preparation of thick and thin
blood films, haematocrit and filter paper blot samples
(Schleicher & Schuell number 903™ filter paper, Dassel,
Germany). Axillary temperature and details of symptoms
potentially due to malaria (reported fever, headache,
body pain, shivering, nausea, vomiting, abdominal pain
and diarrhoea) were recorded. Results of blood film
examination and the haematocrit were sent to partici-
pants within two days of sampling, and medical advice
and treatment were given when necessary.
Laboratory methods
Blood slides were processed and read according to quality-
controlled procedures as described elsewhere [22]. Hae-
matocrit values were determined in a microcapillary after
centrifugation for 5 min at 9000 g. All samples positive by
light microscopy, those with a haematocrit less than 33%,
and 30% of the remaining negative slides, were analysed
by polymerase chain reaction (PCR) for msp2 and restric-
tion-fragment length polymorphism (RFLP). A piece cor-
responding to approximately 1/8th of the blot on the filter
paper was used for a nested PCR amplification of msp2
and genotyping by restriction with enzymes as described
elsewhere [23]. A negative control, to which no DNA had
been added, and a positive control, to which P. falciparum
clone 3D7 DNA (50 ng) had been added were included in
each set of amplification reactions.Malaria Journal 2007, 6:3 http://www.malariajournal.com/content/6/1/3
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Data analysis
Data were double entered using Visual Fox Pro 5.0 and
statistical analyses were performed using Stata5. Fever was
defined as an observed axillary temperature ≥37.5°C and/
or patient-reported fever within the previous 24 h. Clini-
cal malaria was defined as fever with a positive blood slide
for asexual P. falciparum parasites. Anaemia was defined as
a haematocrit <33%. The summary measures consisted of
percentage for categorical variables and means for contin-
uous variables. Parasite densities are reported as the geo-
metric mean of parasite-positive samples. The prevalence
of sub-microscopic infections was calculated as the
number of the PCR-positive samples which had been neg-
ative by microscopic examination divided by the total
number of PCR-positive samples. Multiplicity of infection
(MOI) was defined as the number of distinct msp2-geno-
types detected in infected samples. Student's t-test and lin-
ear regression were used to assess differences between
quantitative variables. The age trends of the different cate-
gorical variables were assessed using the Chi-square test
for linear trend. The association between parasite density
and MOI was calculated separately for each age group by
multiple regression analysis. Categorical variables such as
sex, positivity by PCR and microscopy, anaemia and pres-
ence or absence of symptoms were analysed using Chi-
square and logistic regression. A p-value of 0.05 was con-
sidered statistically significant. Sensitivity and specificity
of the malaria case definition was evaluated using the
attributable fraction of fever due to malaria as described
elsewhere [24].
Ethical clearance
This study fell within the national clearance granted in
1996 to the malaria epidemiology studies of the Manhiça
Health Research Center by the Ministry of Health/
National Institute of Health of Mozambique.
Results
Among the 500 names selected from the census, 137 were
not traceable. Eleven of the remainder had taken antima-
larials, 12 were pregnant and 91 were absent on the day of
the survey. Thus, the study included 249 adults whose
mean age was 37 years (range 15 to 83 years). In concord-
ance with the overall sex distribution of the adult popula-
tion in the area, two thirds of the subjects were female.
Parasitaemia as detected by microscopy was found in
14.4% of subjects (36/249). All infections were due to P.
falciparum. Only one subject had gametocytes. Prevalence
of parasitaemia by microscopy decreased significantly
with increasing age (p < 0.001) (Figure 1). The geometric
mean parasite density was 336 parasites/µl (range 32 to
20376 parasites/µl), and also decreased with age, but this
relation was not significant (p = 0.31) (Figure 1).
A total of 180 samples, selected as defined above, were
analysed by PCR. The prevalence of P. falciparum infection
determined by PCR was 42%, and significantly decreased
with age (p < 0.001) (Figure 1). The proportion of sub-
microscopic infections increased significantly with age (p
= 0.02) (Figure 1). A small number (8.3%) (3/36) of the
parasite positive samples by microscopy were negative by
PCR while 34.7% (50/144) of the samples negative by
light microscopy were positive by PCR. The specificity of
light microscopy was 96.9% but the sensitivity only
37.5%.
All PCR-positive samples were analysed for MOI by RFLP.
Of these 50.6% (41/81) consisted of a single msp2 geno-
type, 23.5% were double infections, 14.8% triple, 9.9%
quadruple, and a quintuple infection. The mean MOI was
1.9. There was an inverse association between age and
MOI (p = 0.009) (Figure 1). Doubling the age, reduced the
MOI by 20.0%. Subjects with microscopically detectable
parasites were more likely to have multiple infections
than those who were just PCR positive (p = 0.010). After
adjusting for age, there was a positive association between
parasite density and MOI (p = 0.001). Every new infection
increased the mean geometric parasite density by a factor
of 1.98.
The mean axillary temperature was 36.1°C (range 35.1°C
to 37.3°C). None of the adults had fever at the moment
of the examination. No significant associations were
found between mean temperatures and the prevalence of
any symptom, but a significant inverse relationship was
found between age and temperature. Doubling age
decreased temperature by 0.05°C (p = 0.004). Prevalences
of symptoms are shown in Table 1.
Anaemia (haematocrit < 33%) was found in 9.8% (24/
245) of the subjects (in 4 the haematocrit could not be
measured). Twenty-two of the 24 anaemic subjects were
females. Haematocrit values were not related to age (p =
0.5). After adjusting for sex, PCR positive subjects had a
haematocrit 2.0% lower than the PCR negative subjects (p
= 0.002).
Clinical malaria, as defined above, was found in 2.4% of
the subjects (6/249). The estimated attributable fraction
of fever due to malaria was 6.7%. The specificity of our
definition was estimated as 91% (95% CI 81% to 98%).
Among parasitaemic adults, there was a significant associ-
ation between high parasite densities and the presence of
diarrhoea (p = 0.004) or headache (p = 0.014), and an
inverse association between shivers and parasite density
(p = 0.029). No relationship was found between MOI and
any symptom.Malaria Journal 2007, 6:3 http://www.malariajournal.com/content/6/1/3
Page 4 of 6
(page number not for citation purposes)
Discussion
This study, one of the few focussing on malaria in adults
from a malaria hyperendemic area [7,12,15-19], has
shown a high discordance between P. falciparum preva-
lence as determined by microscopy (14%) and PCR
(42%). Estimates of infection determined by microscopy
are probably unreliable in adults because of the high prev-
alence of P. falciparum infections with densities below the
detection threshold of blood film examination. Even
prevalence of PCR detected parasites and MOI may be
underestimated when parasites reach such low levels that
densities fluctuate around the threshold limit of the PCR
[25]. This interpretation is supported by the density-
dependent constraints of the PCR found in our study;
multiple P. falciparum clones are differentiated more effi-
ciently in high-density infections.
The abundance of sub-microscopic infections in adults
from Manhiça and the low specificity of signs and symp-
toms hamper the definition of a malaria episode. Fever
was not detected at the time of examination in any of the
adults in this study. Other symptoms such as diarrhoea,
shivering and headache, combined with the presence of
parasitaemia, could be used to formulate a more sensitive
definition of malaria in adults. Special emphasis should
be paid to anaemia. In our study area, the significantly
higher frequency of anaemia cases among PCR positive
individuals might have been due to a reduction in haema-
Prevalence of Plasmodium falciparum infection as determined by microscopy or PCR, proportion of sub-microscopic infections,  mean geometric density and multiplicity of infection by age in adults from Manhiça Figure 1
Prevalence of Plasmodium falciparum infection as determined by microscopy or PCR, proportion of sub-microscopic infections, 
mean geometric density and multiplicity of infection by age in adults from Manhiça.
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tocrit because of recent high density infections that have
been controlled at the moment of the examination by an
efficient immunity or prior treatment. Alternatively, it
may have been the result of persistent asymptomatic
infections that significantly increase the risk of becoming
anaemic.
During the dry season, almost half of the adults from
Manhiça were infected by P. falciparum, as detected by
PCR. Parasite rate might be even higher during the wet
season. Studies in other settings have found similar high
prevalences [25], showing that cumulative prevalence of
parasite carriers over a year is close to 100% [26]. This
prevalent carriage of parasites can be due to a chronic
nature of malaria infections, or to frequent reinfections
which only reach low blood-stage densities before being
eliminated. Most of the infections in our study subjects
were asymptomatic, indicating the occurrence of host
immunity able to restrict parasites to low densities with a
sub-clinical course, although these immune mechanisms
cannot achieve permanent sterility. Importantly, immu-
nity seems to develop during the whole life, as suggested
by the continuous increment in the prevalence of sub-
microscopic infections and the trend towards a reduction
of parasite densities, which may not reach statistical sig-
nificance because of the impossibility to assign accurate
densities to sub-microscopic infections by conventional
PCR methods.
Two forms of antimalarial immunity are believed to
occur, an anti-disease and an anti-parasite immunity [27].
The first one, reflected by the age evolution of fever, is
believed to develop rapidly, reducing the frequency of
clinical presentation of malaria. The second is said to be
slowly acquired, leading to a progressive decrease in para-
site prevalence and MOI. However, the immune ability to
control the parasite may be better reflected by parasite
densities rather than by the prevalence of parasites. We
have reported previously that in the Manhiça district of
Mozambique, both parasite densities and incidence of
clinical malaria decline in parallel during the second half
of infancy [28,29], suggesting that immune mechanisms
able to control parasite densities result in less severe
symptoms. In this community anti-disease and anti-para-
site immunity seem to develop concomitantly and do not
necessarily reflect two different aspects of the host defence
mechanisms against malaria.
Conclusion
This study has evidenced the abundance of sub-micro-
scopic infections in adults from Manhiça. Estimates of
infection determined by microscopy are probably unreli-
able, suggesting that the method of parasite detection may
have a significant effect on the observed natural history of
malaria infections in adults. The increment with age in the
prevalence of sub-microscopic infections, together with
the trend towards a reduction of parasite densities, sug-
gests that immunity in adults develops during the whole
life. This immunity is able to restrict P. falciparum parasites
to low densities with a sub-clinical course, but is not ster-
ilizing. A more sensitive definition of malaria in adults
should be formulated, considering other symptoms such
as diarrhoea, shivering and headache, combined with the
presence of parasitaemia.
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Table 1: Prevalence of symptoms and signs in the study 
population (n = 249).
SYMPTOM/SIGN Prevalence (%)
Individual symptoms
Reported fever 15.7
Headache 23.3
Body pain 14.1
Shivering 12.1
Nausea 12.9
Vomiting 5.6
Abdominal pain 37.4
Diarrhoea 6.8
Number of symptoms experienced
No symptoms 48.6
One symptom 24.9
2/3 symptoms 12.5
4+ symptoms 14.1
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